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Abstract
Background: Listeria monocytogenes, an intracellular foodborne pathogen, infects immunocompromised hosts. The primary
route of transmission is through contaminated food. In the gastrointestinal tract, it traverses the epithelial barrier through
intracellular or paracellular routes. Strategies to prevent L. monocytogenes entry can potentially minimize infection in high-
risk populations. Listeria adhesion protein (LAP) aids L. monocytogenes in crossing epithelial barriers via the paracellular
route. The use of recombinant probiotic bacteria expressing LAP would aid targeted clearance of Listeria from the gut and
protect high-risk populations from infection.
Methodology/Principal Findings: The objective was to investigate the ability of probiotic bacteria or LAP-expressing
recombinant probiotic Lactobacillus paracasei (Lbp
LAP) to prevent L. monocytogenes adhesion, invasion, and transwell-based
transepithelial translocation in a Caco-2 cell culture model. Several wild type probiotic bacteria showed strong adhesion to
Caco-2 cells but none effectively prevented L. monocytogenes infection. Pre-exposure to Lbp
LAP for 1, 4, 15, or 24 h
significantly (P,0.05) reduced adhesion, invasion, and transepithelial translocation of L. monocytogenes in Caco-2 cells,
whereas pre-exposure to parental Lb. paracasei had no significant effect. Similarly, Lbp
LAP pre-exposure reduced L.
monocytogenes translocation by as much as 46% after 24 h. Lbp
LAP also prevented L. monocytogenes-mediated cell damage
and compromise of tight junction integrity. Furthermore, Lbp
LAP cells reduced L. monocytogenes-mediated cell cytotoxicity
by 99.8% after 1 h and 79% after 24 h.
Conclusions/Significance: Wild type probiotic bacteria were unable to prevent L. monocytogenes infection in vitro.I n
contrast, Lbp
LAP blocked adhesion, invasion, and translocation of L. monocytogenes by interacting with host cell receptor
Hsp60, thereby protecting cells from infection. These data show promise for the use of recombinant probiotics in
preventing L. monocytogenes infection in high-risk populations.
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Introduction
Listeria monocytogenes causes a severe systemic infection (listeriosis)
and poses a significant health risk to pregnant women, newborns,
the elderly, and other immunocompromised individuals [1].
Annually, about 2,500 Americans contract invasive listeriosis with
a mortality rate of 20–30% [2]. Traditional vaccination is not
economical for the treatment and control of listeriosis owing to the
small number of cases. Given increasing concerns about antibiotic
resistance, the emergence of ‘‘superbugs’’ [3–5], and the lack of
targeted treatments, recombinant lactobacilli expressing the genes
required for pathogen adhesion and colonization, such as Listeria
adhesion protein (LAP), might selectively prevent infection
because adhesion and colonization are primary and crucial steps
in pathogenesis [6]. A need exists for novel and effective strategies
to prevent listeriosis in susceptible populations, but it requires a
better understanding of the intestinal phase of L. monocytogenes
infection.
Listeriosis is predominantly contracted through contaminated
food, although neonatal listeriosis is acquired from the mother.
During the gastrointestinal phase of infection, intestinal epithelial
cells and M (microfold) cells are the primary sites of interaction.
Adhesion, invasion, and translocation across the intestinal
epithelial barrier are a prerequisite for pathogenesis [6–8].
Therefore, devising strategies to block the initial site of pathogen
interaction is an effective and logical approach to protecting hosts
against enteric infections [9,10].
LAP is an alcohol acetaldehyde dehydrogenase (lmo1634), a
housekeeping enzyme with a molecular mass of about 104 kDa
[11]. It interacts strongly with host cells of intestinal origin [12,13]
and binds to host cell receptor Hsp60 [14]. More specifically, the
N2 domain (Gly224 – Gly411) in the N-terminus of LAP interacts
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29277with Hsp60 [15]. Surface expression and secretion of LAP
depend on SecA2, an auxiliary secretion system present in gram-
positive bacteria [11,16]. Our previous studies have demonstrated
that LAP expression is enhanced in oxygen- and nutrient-limited
conditions and at elevated temperatures (37–42uC) [16–18]. In
the intestine, L. monocytogenes crosses the epithelial barrier by
invading epithelial cells through the intracellular route using
Internalin (InlA or InlB) proteins [19,20]. Our recent data have,
for the first time, shown that Listeria can also cross the epithelial
barrier via the paracellular route [21]. Interaction of LAP with
Hsp60 compromises the tight junction barrier, allowing increased
paracellular translocation of L. monocytogenes. Furthermore, L.
monocytogenes translocation occurs independently of InlA: a DinlA
mutant strain translocated efficiently through the epithelial
barrier [21].
Probiotic bacteria have long been used to promote human
health [22]. These bacteria colonize and proliferate in the
intestine, producing metabolites and macromolecules with bene-
ficial effects including health maintenance and prevention or
alleviation of enteric infection, allergic diseases, and chronic
inflammatory diseases such as inflammatory bowel disease,
Crohn’s disease, and ulcerative colitis [3,4,23–25]. The use of
probiotics to prevent and treat infections is gaining attention as a
substitute for antibiotic or anti-inflammatory drugs because
antibiotic resistance [26] and the emergence of ‘‘superbugs’’
threaten public health [3–5]. One of the most critical functions of
probiotics is infection prevention, likely mediated by increased
defensin production, induction of anti-inflammatory responses,
suppression of pro-inflammatory cytokines (i.e., tumor necrosis
factor a, interleukin [IL]-8, IL-6), increased production of short-
chain fatty acids (butyrate) during fermentation, and improved
epithelial tight junction barrier function [27–31]. Probiotic
bacteria attach to intestinal cells via electrostatic or hydrophobic
interactions, steric forces, lipoteichoic acids, or specific surface
proteins [24,32] and prevent pathogen binding through a
mechanism referred to as steric hindrance [33,34]. Probiotic
bacterial cells [35], cell wall components such as S-layer proteins
[27], and secretory compounds are also known to prevent enteric
pathogen colonization [36] and neutralize toxins [37]. Although
many enteric diseases have been controlled by probiotics, the
approach has had limited success or been ineffective with L.
monocytogenes [3,33]. Furthermore, the normal anti-pathogen
adhesive activity of probiotics is often unpredictable and
unsatisfactory and may be unsuitable for inhibiting the attachment
of specific pathogens to a host.
Genetic modification of probiotic bacteria to respond to target
pathogens and toxins or to deliver biologics such as anti-
inflammatory cytokines has become highly attractive [38–41].
Probiotic bacteria are generally regarded as safe and widely used
in commercial probiotic products. Genetic modification allows for
targeted pathogen elimination. For example, probiotic bacteria
have been engineered to prevent E. coli heat-labile toxin [42] and
cholera toxin binding to host receptors [43], Helicobacter pylori
infection by expressing urease B [44], and HIV infection by
expressing HIV-specific CD4 receptors [45] and to control
Salmonella enterica infection by expressing flagellar antigen [46].
The objective of this study was to develop a recombinant
probiotic strain expressing LAP to exclude adhesion, transepithe-
lial translocation, and cell cytotoxicity of L. monocytogenes compet-
itively in a cell culture model. We expected that a genetically
engineered probiotic would exert its antimicrobial effect against
the target pathogen directly through the expression of a foreign
gene and indirectly through beneficial properties inherent in
probiotics.
Results
Lactobacilli Showed Highest Attachment to Caco-2 Cells
The ability to adhere to or colonize epithelial cells is an essential
and prerequisite trait for probiotic bacteria [47,48]. To select the
most suitable candidate for genetic modification, we screened the
attachment profiles of several lactic acid bacteria (LAB), including
some well-characterized probiotics (Lactobacillus spp.) and bacte-
riocin-producing strains (Pediococcus and Lactococcus) to Caco-2 cells
(Table 1; Fig 1). As reference controls, adhesion of L. monocytogenes
F4244 (wild type [WT]) and the lap-deficient isogenic strain
KB208 were also analyzed, showing about 9.78% and 0.84%
adhesion, respectively. Attachment of LAB to Caco-2 cells varied
from 0.78% to 23.8% with Lactobacillus rhamnosus showing the
highest (23.8%) adhesion, followed by Lb. plantarum (16.9%), Lb.
gasseri (16.6%), Lb. casei (11.8%), and Lb. paracasei (10.2%). Lb.
acidophilus, Pediococcus, and Lactococcus attached to Caco-2 cells in
significantly lower numbers than those of L. monocytogenes
(P,0.0001). From this study, a representative strain of highly
adherent Lb. rhamnosus, moderately high Lb. paracasei, and low-
adherent Lb. acidophilus were chosen for subsequent experiments.
Wild Type Lactobacilli Did Not Reduce L. monocytogenes
Infection in Caco-2 Cells
We used three experimental approaches to examine whether
the selected lactobacilli would reduce L. monocytogenes adhesion to
Caco-2 cells, [10]: competitive exclusion, inhibition of adhesion,
and displacement (Fig S1). Surprisingly, none of the lactobacilli
reduced the adhesion of L. monocytogenes at significant levels
regardless of method used (Fig S1), despite their uniform
attachment to Caco-2 cells throughout the study. Five additional
LAB strains also did not displace attached L. monocytogenes from
Caco-2 cells (Fig S2a). We examined whether increased concen-
trations of lactobacilli could reduce L. monocytogenes adhesion.
Lactobacilli added in 100-fold greater numbers also failed to
displace attached L. monocytogenes (Fig S2b). These data clearly
indicated that lactobacilli and other tested LAB strains were
unable to reduce or prevent L. monocytogenes adhesion or
colonization on epithelial cell surfaces, even in higher numbers.
LAP of L. monocytogenes Cloning and Expression in Lb.
paracasei
Because none of the WT LAB showed any discernable
inhibition of L. monocytogenes, we sought to determine whether
LAP expression in probiotic bacteria would reduce L. monocytogenes
infection in the competitive exclusion experiments. We first cloned
the lap gene in a Lactobacillus expression vector, pLP401-T [49,50]
(Fig 2a), and transformed it into Lb. paracasei (Table 1), which had
an intermediate level of attachment to Caco-2 cells (see Fig 1;
Note: the pLP401-T vector was originally designed for heterolo-
gous gene expression in Lb. paracasei and Lb. casei, hence we used
Lb. paracasei to express L. monocytogenes LAP). Protein expression in
recombinant Lb. paracasei (Lbp
LAP) cell fractions was analyzed with
Western blot. Data indicated that LAP was present in the
supernatant (SN), cell wall (CW), and intracellular fractions
(Fig 2b). Aminopeptidase C (PepC) assay confirmed that the SN
and CW fraction had no apparent contamination from intracel-
lular proteins (data not shown). Furthermore, anti-LAP MAb EM-
H7 showed no reaction with protein bands from Lb. paracasei WT
(Lbp
WT) (see Fig 2b). These data indicated that LAP is surface
associated in Lbp
LAP cells and would be available for interaction
with mammalian cells. Additionally, immunofluorescence staining
using anti-LAP MAb confirmed the surface localization (Fig 2c).
LAP interacts with mammalian protein receptor Hsp60 [14]. To
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LAP would interact
with Hsp60, purified mammalian Hsp60 protein was immobilized
on paramagnetic beads [51], and the capture rate of Lbp
LAP cells
was determined relative to L. monocytogenes capture. If the bead-
based capture efficiency of L. monocytogenes WT was considered
100%, the percent relative capture for Lbp
LAP cells was 86.5%,
which was 4.4-fold higher than that of Lbp
WT (19.6%; Fig 2d). In
a separate experiment, we also showed that pretreatment of Caco-
2 cells with anti-Hsp60 monoclonal antibody (1 mg/ml) [14,21]
affected Lbp
LAP binding and subsequently L. monocytogenes adhesion
(Fig S4). Collectively, these data confirmed that LAP of L.
monocytogenes was successfully expressed in Lb. paracasei and surface-
associated LAP efficiently interacted with Hsp60.
Lbp
LAP Adherence and Translocation through Caco-2 Cell
Monolayers
We also examined the adhesion and transepithelial transloca-
tion characteristics of recombinant Lbp
LAP in Caco-2 cells. The
data showed a significant increase (P=0.0009) in adhesion of
Lbp
LAP compared to Lbp
WT (Fig 3a), demonstrating the
involvement of LAP in adhesion. Giemsa staining of the Caco-2
cell monolayer also provided visual confirmation of qualitative
increase in adhesion for Lbp
LAP cells (Fig 3b). LAP involvement
was further verified by pre-treatment of Lbp
LAP cells with anti-
LAP monoclonal antibody (MAb-H7) which reduced adhesion by
4.3% compared to antibody-untreated Lbp
LAP cells or cells treated
with isotype immunoglobulin G control antibody (Fig 3a).
Recently, we reported that LAP promotes L. monocytogenes
translocation through epithelial cells using the paracellular route
[21]. In this study, we examined whether Lbp
LAP had transloca-
tion ability similar to that of L. monocytogenes. Using a standard
transwell setup, we showed that Lbp
LAP cells translocated through
Table 1. Bacterial strains and plasmids.
Bacteria/plasmids Strains Description Source
Listeria monocytogenes F4244 Wild type, serotype 4b Our collection
L. monocytogenes KB208 F4244, LAP deficient strain (Em
R 5 mg/mL) Our laboratory
L. innocua F4248 Wild type Our collection
Lactobacillus acidophilus NRRL B1910 Wild type Our collection
Lb. casei KCTC 3109 Wild type KCTC
Lb. gasseri ATCC19992 Wild type ATCC
Lb. paracasei DUP13076 Wild type Lactrys BiopharmaceuticalsBV (Netherlands)
Lb. paracasei LAP
+ (AKB901) Lb. paracasei expressing LAP of L. monocytogenes (Em











Lb. rhamnosus GG ATCC53103 Wild type ATCC
Pediococcus acidilactici H Pediocin AcH-producing strain, Wild type B. Ray (University of Wyoming)
Ped. acidilactici RS2 Pediocin RS2-producing strain; Wild type Our collection
Lactococcus lactis ATCC 7962 Wild type ATCC
Lac. lactis ATCC 11454 Nisin-producing strain; Wild type ATCC
Plasmids
pGEM-T easy Cloning vector (Am
R 50 mg/mL) Promega
pGEM-LAPLm pGEM-Teasy carrying lap of L. monocytogenes This study
pLP401T Expression vector for Lactobacillus,( A m
R 50 mg/mL and Em
R 2 mg/mL) [49]
pLP401-LAP pLP401 carrying lap of L. monocytogenes This study
KCTC, Korean Type Culture Collection; ATCC, American Type Culture Collection; NCDO, National Collection of Dairy Organisms.
doi:10.1371/journal.pone.0029277.t001
Figure 1. Adhesion profile of lactic acid bacteria to Caco-2
cells. Bacteria were added to Caco-2 cells at a ratio of 10:1. Percent
adhesion was calculated relative to the inoculums that were added to
the Caco-2 cells for the adhesion assay. The data are average (SD) of
two independent experiments performed in triplicate. Bars marked with
letters (a, b, c, d) are significantly different at P,0.05.
doi:10.1371/journal.pone.0029277.g001
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(P,0.0001) higher—than that of Lbp
WT (Fig 4a). We also
examined the internalization of Lbp
LAP by Caco-2 cells.
Interestingly, Lbp
LAP cells were internalized at about a 3.5-fold
higher level than that of the Lbp
WT (Fig 4b).
Lbp
LAP Reduces L. monocytogenes Adhesion and
Transepithelial Translocation through Caco-2 Cell
Monolayers
We also investigated the ability of Lbp
LAP to reduce or prevent
L. monocytogenes attachment to Caco-2 cells using the three
competitive exclusion assays. In the competitive adhesion
experiment, Caco-2 cells were exposed to Lbp
LAP, Lbp
WT, and
L. monocytogenes for 1 h each before bacterial enumeration. In the
competitive adhesion assay, adhesion of L. monocytogenes was
reduced by 31.0% (Fig 5a), and in the inhibition of adhesion
assay, reduction was 24.6% compared to that of L. monocytogenes
alone (Fig 5b). No significant difference in displacement of L.
monocytogenes occurred with Lbp
LAP (P=0.3147; Fig 5c). Inhibition
in adhesion of lap-deficient mutant L. monocytogenes KB208 by
Lbp
LAP (negative control) was not observed. Overall, the
recombinant strain effectively excluded L. monocytogenes when
added before (inhibition of adhesion) or simultaneously (compet-
itive adhesion) but not after L. monocytogenes has already adhered
(displacement assay). We also monitored the adhesion of Lbp
LAP
cells. These cells showed a 21.7% reduction in binding during
competitive adhesion with L. monocytogenes, whereas no reduction
occurred in the displacement assay; however, Lbp
LAP cell adhesion
was significantly reduced after the inhibition assay (44.1%
reduction) [52].
Using the competitive adhesion assay, we determined the effect
of Lbp
LAP cell pre-exposure on Caco-2 cells for 1, 4, 15, and 24 h
and the reduction of L. monocytogenes infection—i.e., adhesion,
invasion, and transepithelial translocation. The data showed that
Lbp
LAP cells reduced L. monocytogenes adhesion by 21%, 26%, 33%,
and 44%, respectively, whereas Lbp
WT exposure resulted in only a
3.5%-14.6% reduction during the same period (Fig 6a). Invasion
experiment showed that Lbp
LAP reduced L. monocytogenes invasion
by 8.3%, 7.3%, 27.6%, and 44.7%, respectively (Fig 6b).
Transepithelial translocation experiments demonstrated highly
Figure 2. Listeria adhesion protein (LAP) expression analysis in recombinant Lactobacillus paracasei (Lbp
LAP). (a) Plasmid map (10.6 kb) of
LAP expression vector pLP401T (9.8 kb)-LAP (2.6 kb) [50]. Ery, erythromycin resistance gene; Amp, ampicillin resistance gene; Ori+=origin of
replication of E. coli, Ori-= origin of replication of Lactobacillus; LAP, Listeria adhesion protein; Pamy, a-amylase promoter gene; ssAmy, secretion
signal (36 aa) and the N-terminus (26 aa) of a-amylase gene; Anchor, anchor peptide (117 aa) gene of Lb. casei; Tcbh, transcription terminator of the
cbh (conjugated bile acid hydrolase) gene; Rep, repA gene. (b) Western blot showing LAP expression in the supernatant, cell wall, and intracellular
fractions of Listeria monocytogenes (Lm) and Lbp
LAP but absent in wild type Lb. paracasei (Lbp
WT). Molecular weight of LAP from Lm and the
recombinant Lbp
LAP was similar. (c) Immunofluorescence staining of bacteria (magnification 10006) with anti-LAP MAb-H7 and fluorescein
isothiocyanate-conjugated second antibody (left panel) and Hoechst dye (blue; right panel). Lbp
LAP and Lm (control) cells indicated the presence of
surface-expressed LAP (green) that was absent in Lbp
WT. (d) Binding (capture) of recombinant Lb. paracasei cells to paramagnetic beads coated with
Hsp60 relative to L. monocytogenes (considered 100%). The data are average (SD) of two independent experiments performed in duplicate. Letters (a,
b) indicate significant difference at P,0.05.
doi:10.1371/journal.pone.0029277.g002
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LAP reduced L.
monocytogenes translocation by 15.3%, 31.8%, 36.8%, and 46.3% in
1, 4, 15, and 24 h, respectively (Fig 6c), whereas Lbp
WT had no
significant effect. In these experiments, a vector control, devoid of
lap insert (Lbp
LAP-) was included to rule out the involvement of any
plasmid encoded proteins (pLP401-T) that may exert protective
effect against L. monocytogenes (Fig 6). Together, these data indicate
that increased preoccupation of Hsp60 on Caco-2 cells by growing
Lbp
LAP cells overtime significantly (P,0.05) reduced L. monocyto-
genes adhesion, invasion, and translocation though epithelial
barriers.
Lbp
LAP Reduces L. monocytogenes-Induced Tight
Junction Permeability
L. monocytogenes may alter tight junction permeability to allow for
its own translocation through the epithelial barrier [21]. Hence,
we monitored Caco-2 tight junction integrity using the well-
established dextran fluorescein isothiocyanate (Dextran
FITC)
permeability assay. After infection with L. monocytogenes for 2 h,
about 2.6% of the apical Dextran
FITC was recovered from the
basolateral chamber, indicating a compromise in tight junction
integrity. In contrast, pre-exposure of Caco-2 monolayers to
Lbp
LAP for 1–24 h before L. monocytogenes infection reduced
Dextran
FITC recovery to 0.3% or less (Table 2), a level equivalent
to that from uninfected Caco-2 cells. These data demonstrated
that Lbp
LAP can protect Caco-2 cells from L. monocytogenes-
mediated cell damage and tight junction compromise. Likewise,
we monitored tight junction integrity by measuring transepithelial
electrical resistance (TEER; Table 3). Percent change in TEER
values for Caco-2 cells pre-exposed to Lbp
WT followed by 2 h of
treatment with L. monocytogenes varied from 8.8% to 14.5%;
however, values for Lbp
LAP-treated cells followed by L. monocyto-
genes infection was only 1.4% – 6.4%. These data confirm the
ability of Lbp
LAP to prevent L. monocytogenes translocation through
epithelial cell barriers, possibly by maintaining tight junction
integrity (see Fig 6).
Figure 3. Adhesion characteristics of recombinant Lactobacillus paracasei (Lbp
LAP) to Caco-2 cells. (a) Adhesion of Lbp
LAP was compared
with wild type Lb. paracasei (Lbp
WT) and L. monocytogenes (Lm). Bacterial cells were incubated with anti-LAP MAb-H7 or immunoglobulin G controls
(MAb EM-7G1) (1 mg/ml) for 30 min at room temperature, washed and added to Caco-2 cells. The number of bacterial cells that adhered to the
monolayer were enumerated. Percent adhesion was calculated relative to the inoculums that were added to the Caco-2 cells for the adhesion assay.
Data are average (SD) of three independent experiments performed in duplicate. Bars marked with letters (a, b) indicate significant difference at
P,0.05. (b) Representative Giemsa-stained Caco-2 cell monolayers showing visual evidence for qualitative adhesion characteristics of Lbp
WT and
Lbp
LAP cells. Bar, 10 mm.
doi:10.1371/journal.pone.0029277.g003
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LAP Reduces L. monocytogenes-Induced Cell
Cytotoxicity
L. monocytogenes induces severe cell cytotoxicity in mammalian
cells [53]. We examined whether Lbp
LAP could protect Caco-2
cells from this cytotoxicity. Lactate dehydrogenase assay indicated
that Lbp
LAP reduced L. monocytogenes-mediated cytotoxicity by
99.8% after 1 h of pre-exposure, 88.8% after 4 h, 80% after 15 h,
and 79% after 24 h, whereas Lbp
WT demonstrated no discernable
protective effects (Table 4). Reduced Lbp
LAP-mediated protection
after 15 and 24 h of pre-exposure may be due to the overgrowth of
Lbp
LAP and consequent production of metabolic by-products with
adverse effects on Caco-2 cells, which make them more vulnerable
to L. monocytogenes-mediated cell damage. Under in vivo conditions,
these by-products would most likely be processed by luminal cells
or natural microflora [54]. Reduced cytotoxicity was also verified
with live and dead staining of Caco-2 cells using acridine orange
(AO) and propidium iodide (PI). L. monocytogenes-infected Caco-2
cells pretreated with and without Lbp
WT for 15 h appeared
orange-red, indicating that the majority of cells were either dead
or their cell membranes were severely compromised. When the
Caco-2 cells were pre-exposed to Lbp
LAP before L. monocytogenes
infection, however, they appeared bright green, indicating that
they were similar to uninfected controls (Fig 7).
Discussion
Immunocompromised populations such as pregnant women
and their fetuses, infants, the elderly, HIV-infected patients, and
patients receiving chemotherapy are most vulnerable to infectious
diseases [1,55,56]. Increasing concerns about antibiotic resistance
[26], the emergence of superbugs [5], and the lack of targeted
treatments has created renewed interest in using probiotic bacteria
against these diseases [3,22,23]. In this respect, recombinant
probiotics expressing genes that are required for pathogen
adhesion and colonization [3] are even more attractive targets
because these steps are primary and critical for pathogenesis. In L.
monocytogenes pathogenesis, adhesion, invasion, and translocation of
intestinal epithelial barriers are crucial during the gastrointestinal
phase of infection [7,8]. Blocking the initial adhesion/invasion of
L. monocytogenes would be a rational strategy for controlling
infection. Recently, we have shown that LAP promotes L.
monocytogenes translocation through epithelial barriers via the
paracellular route [21]. In addition, it induces increased Hsp60
production, allowing for greater secondary infection with L.
monocytogenes [21].
Probiotic bacteria are considered safe and have health benefits.
Probiotics are also known to exclude enteric pathogens or
neutralize toxins [4,57]. Genetically engineered probiotics have
been shown to be effective against E. coli heat-labile toxin (LT) and
cholera toxin [42,43], Helicobacter pylori [44], HIV [45], and
Salmonella enterica infections [46]. Probiotics also prevent pathogen
infections by increased defensin production, induction of anti-
inflammatory responses and suppression of pro-inflammatory
cytokines, increased production of short-chain fatty acids and
Figure 4. (a) Translocation and (b) internalization of recombi-
nant Lactobacillus paracasei (Lbp
LAP) and wild type Lb. paracasei
(Lbp
WT). In the translocation assay, Caco-2 cells were grown on
transwell filter inserts for 10–12 days to differentiate and to reach
confluence. Bacteria were added to the apical well of the insert and
incubated for 2 h. Liquid from the basal well was removed and plated
for bacterial enumeration. In the invasion assay, bacteria were added to
Caco-2 cells at an MOE of 10:1/well in 24-well tissue culture plates and
incubated for 1 h. After washing (3X), Caco-2 cells were incubated in
D10F containing 50 mg/mL gentamicin, lysed using 0.1% Triton-X 100
and intracellular bacteria were enumerated following plating. The data
are average (SD) of three independent experiments analyzed in
duplicate.
doi:10.1371/journal.pone.0029277.g004
Figure 5. Competitive exclusion of Listeria monocytogenes (Lm)
adhesion to Caco-2 cells by recombinant Lactobacillus paracasei
(Lbp
LAP), analyzed by three adhesion methods. (a) competitive
adhesion: Caco-2 cells were exposed to wild type Lb. paracasei (Lbp
WT)
or Lbp
LAP with Lm simultaneously, (b) inhibition of adhesion: Caco-2
cells were pre-exposed to Lbp
WT or Lbp
LAP for 1 h before infection with
Lm, and (c) displacement experiments: Caco-2 cells were infected with
Lm for 1 h before Lbp
WT or Lbp
LAP addition. Adhesion of (Lm) alone to
Caco-2 cells was presented as 100%. Lap-deficient LmKB208 was used
as a negative control in the competitive adhesion assay. The data are
average (SD) of three independent experiments performed in duplicate.
Bars marked with letters (a, b) indicate significant difference at P,0.05.
doi:10.1371/journal.pone.0029277.g005
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we were interested in generating recombinant probiotic bacteria
expressing LAP for potential control of L. monocytogenes infection.
Initially, the adhesion ability of LAB to Caco-2 cells was
screened to find strains useful for LAP expression. Although
adhesion profiles varied widely among LAB strains, overall, it was
Figure 6. Inhibition of Listeria monocytogenes (Lm) adhesion, invasion, and transepithelial translocation by recombinant Lactobacillus
paracasei (Lbp
LAP). Caco-2 cells were exposed to Lbp
LAP, Lbp
LAP- (vector without LAP insert) or wild type (Lbp
WT) for 1, 4, 15, and 24 h before
infection with Lm for 1 h in (a) adhesion and (b) invasion experiments, and 2 h for (c) transepithelial translocation experiments. Data are averages of
three experiments run in triplicate. Bars marked with letters (a, b, c, d) are significantly different at P,0.05. Table below each graph shows average log
Lm counts (SD) for each treatment.
doi:10.1371/journal.pone.0029277.g006
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LAB strains tested, Lb. rhamnosus, Lb. acidophilus, and Lb. paracasei,
all with different adhesion abilities, were selected. The rationale
for choosing three species with broad range of adhesion properties
was that competitive exclusion depends not only on the adhesion
ability of a probiotic strain [60] but also on properties such as acid
and antimicrobial compound production [36,37,61]. Surprisingly,
none of the three species significantly excluded L. monocytogenes
adhesion. Competitive exclusion against other pathogens such as
E. coli O157:H7, Salmonella typhimurium, Campylobacter jejuni, Shigella
boydii, and Staphylococcus aureus was successful using lactobacilli [62–
64]. However, L. monocytogenes had been considered a difficult
organism to inhibit using Lactobacillus species. Botes et al. [65] have
prevented L. monocytogenes Scott A invasion using bacterial cells and
the SN of Enterococcus mundtii and Lb. plantarum, but no effect on
adhesion was observed during competitive exclusion assays.
Another study has shown no significant effect on L. monocytogenes
inhibition by Lb. acidophilus and Lb. casei, whereas Lb. rhamnosus GG
partially blocked L. monocytogenes adhesion [59]. Collado et al. [10]
have shown that bifidobacterium has a greater ability to displace L.
monocytogenes than to inhibit it, but they did not observe significant
reduction in adhesion in displacement and inhibition experiments.
Coconnier et al. [33] have shown that Lb. acidophilus inhibits L.
monocytogenes; however, the effect was dose dependent and more
than 10
9 cfu/mL of Lb. acidophilus was needed.
Among the lactobacilli chosen for our study, Lb. paracasei was
used as the host for generation of the recombinant strain because
the Lactobacillus expression vector pLP401-T delivers protein
effectively due to the presence of a secretion signal, and the
leader sequence of CW proteinase from Lb. paracasei [66]. The
fusion of these sequences with heterologous genes permits
secretion and surface association of heterologous proteins to the
peptidoglycan via anchor encoding sequence, prtP from Lb. casei
[50]. This has been also used to express tetanus toxin fragment C
[49], and single-chain Fv antibody fragment against Streptococcus
mutans [67]. Before initiating the cloning experiment, we verified if
Lb. rhamnosus, Lb. acidophilus, and Lb. paracasei would interact with
Hsp60, because they also carry a LAP homolog (Table S1);
however, a magnetic bead binding experiment (Fig S3) and a
microfluidic biochip experiment [68] revealed no apparent
interaction of these lactobacilli with purified human Hsp60
protein. Western blot analysis also revealed no apparent reaction
of anti-LAP antibody with protein fractions from Lbp
WT (see
Fig 2). We then successfully expressed LAP in Lb. paracasei and
surface-associated LAP from Lbp
LAP interacted strongly with
Hsp60 in a magnetic bead binding experiment (Fig 2).
Additionally, Lbp
LAP also showed greater adhesion, internali-
zation and translocation than that of Lbp
WT to Caco-2 cells. LAP
is not known to promote invasion [21] but the increased
association between Lbp
LAP and epithelial cells might have




FITC recovered in bottom well after Caco-2 cells were pretreated with Lactobacillus paracasei for
variable time periods followed by Listeria monocytogenes treatment for 2 h (Mean [SE])
a
1h 4h 1 5h 2 4h
Lb. paracasei WT (Lbp
WT) 2.1160.04 2.2860.05 2.5660.07 2.5460.12
Lb. paracasei LAP (Lbp
LAP) 0.0960.01 0.3260.02 0.3460.001 0.3460.01
Fold-change 24.8 7.1 7.5 7.5
aCaco-2 cells monolayers were grown in transwell inserts and treated with wild type (WT) or Listeria adhesion protein (LAP)-expressing Lb. paracasei for 1, 4, 15, and
24 h, then treated with L. monocytogenes for 2 h. Tight junction integrity of Caco-2 cells was monitored with Dextran
FITC translocation across the membrane.
Dextran
FITC recovery after L. monocytogenes was 2.6860.03%. Values are averages of three experiments analyzed in triplicate and are significantly different between
Lbp
WT and Lbp
LAP at all time points (P,0.05).
doi:10.1371/journal.pone.0029277.t002
Table 3. Caco-2 cell permeability analysis using transepithelial electrical resistance (TEER).
Treatment Exposure time (h) TEER (Mean V/cm
2 [SE])
a
Before exposure to Listeria
monocytogenes
After exposure to L. monocytogenes
(2 h) % Change
Lactobacillus paracasei WT (Lbp
WT) 1 h 268.663.9 244.964.7 8.8
4 h 269.962.9 239.962.1 10.8
15 h 265.563.3 226.962.2 14.5
24 h 271.462.4 232.963.1 14.2
Lb. paracasei LAP (Lbp
LAP) 1 h 266.563.4 262.963.1 1.4
4 h 267.163.5 261.564.0 2.1
15 h 263.961.5 252.560.8 4.3
24 h 268.764.1 251.563.6 6.4
aCaco-2 cells monolayers were grown in transwell inserts and treated with wild type (WT) or Listeria adhesion protein (LAP)-expressing Lb. paracasei for 1, 4, 15, and
24 h, then treated with L. monocytogenes for 2 h. TEER measurements before and after L. monocytogenes treatment alone were 279.4061.19 and 243.5761.20,
respectively. Values are averages of two experiments analyzed in triplicate and are significantly different between Lbp
WT and Lbp
LAP at all time points (P,0.05). %
Change was calculated as 1 – TEERafter 4 TEERbefore 6100.
doi:10.1371/journal.pone.0029277.t003
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frequently been reported for nonpathogens [69,70]. Nevertheless,
these results provide strong evidence that increased translocation
be mediated by the specific binding of LAP to Hsp60. Lactococcus
lactis expressing InlA of L. monocytogenes or fibronectin binding
protein from S. aureus showed internalization 1000 times higher
than that of the WT [71]. These recombinant bacteria also
transferred plasmids carrying foreign genes into Caco-2 cells,
suggesting potential use of these strains for DNA delivery. Our
recombinant Lbp
LAP strain also shows potential for delivering
foreign proteins to protect hosts against listeriosis or other
infections, a property currently under investigation.
In future, we would like to determine the fate of these
translocated bacteria in the lamina propria in in vivo animal
models following oral administration [28,31] and determine
immune response, if any, to this protein. Since, L. monocytogenes
infection is fatal in immunocompromised hosts we foresee that the
LAP-expressing probiotics can be taken orally as a dietary
supplement in a regular basis by this population during the period
of need such as women during pregnancy, organ transplant
patients receiving immunosuppressive drugs, cancer patients
receiving chemotherapy or the elderly.
Increased translocation of probiotic bacteria may raise potential
health concerns, particularly in immunocompromised patients; a
few cases of sepsis related to translocated Lactobacillus have been
reported in these patients [72]. However, translocated Lactobacilli
are rapidly eliminated by the host immune system and thus may
not be found even when administered in higher doses [73].
Acceptable daily intake of probiotics is 35 g/day for a person
weighing 70 kg, which is much higher than what is normally
consumed and suggests very low risk of infection [72]. Even
though probiotics are considered safe, recombinant strains must be
thoroughly evaluated in vivo for toxicity before use [48].
Competitive adhesion experiments revealed that Lbp
LAP was able
to reduce the adhesion of L. monocytogenes only when it was added
simultaneously or sequentially with L. monocytogenes; however, the
recombinant strain was unable to displace adhered L. monocytogenes.
(see Fig 5). The competition was presumably based on interactions
with Hsp60 expressed on the surface of Caco-2 cells. It is difficult
to displace attached pathogens unless the bacteria are detached
and the recombinant Lactobacillus is allowed to bind to the receptor
to hinder pathogen adhesion. Lee et al. [63] have examined
competitive exclusion of pathogens such as E. coli O157:H7,
Salmonella enteritidis, and S. typhimurium by Lb. rhamnosus GG and
have suggested that displacement was relatively slow and more
difficult, but prolonged exposure of Lactobacillus could remove
adhered L. monocytogenes from Caco-2 cells. The interaction
between Hsp60 and LAP is strong, with a binding affinity of
1.68610
28 M [13]. Thus, prolonged exposure to Lactobacillus
expressing LAP may not result in displacement of adhered L.
monocytogenes. Moreover, during the displacement experiment, the
pathogen may have already proceeded to the next step of the
infection process—i.e., invasion or transepithelial translocation—
before the probiotics had an opportunity to displace them.
Using the competitive adhesion assay, a prolonged exposure (1–
24 h) of Caco-2 cells to Lbp
LAP cells was tested to show increased
inhibition, with the highest reduction noticed after a 24-h pre-
exposure. In addition to a reduction in adhesion and invasion,
prolonged exposure to the recombinant probiotic also significantly
reduced the transepithelial translocation of L. monocytogenes.
Therefore, prolonged exposure to the probiotic (Lbp
LAP) may be
necessary to prevent L. monocytogenes infection. These data indicate
that Lbp
LAP may protect Caco-2 cells via an unknown mechanism
currently under investigation. We speculate that Lbp
LAP increases
tight junction integrity by suppressing the production of TNF-a
and interferon-c as part of a ‘‘leak pathway’’ and subsequently
regulates cytoskeletal protein expressions involved in maintaining
tight junction integrity [9,74]. Our preliminary unpublished data
show that purified recombinant LAP was also able to increase tight
junction permeability in Caco-2 cells allowing increased translo-
cation of a nonpathogenic strain of E. coli suggesting that
recombinant LAP expressing probiotics bacteria cells are required
to provide physical barrier against pathogen invasion and
translocation.
Genetically modified lactic acid bacteria are becoming attrac-
tive vehicles for delivering functional proteins to the mucosal
tissues via oral or intranasal route to induce mucosal immunity
against infectious agents [40]. Thus, the use of a recombinant
probiotic carrying the LAP (Lbp
LAP) could be considered an oral
vaccine to help reduce L. monocytogenes infection in high-risk
populations. Furthermore, the application of such a recombinant
probiotic bacterium would have a two-fold advantage: direct
antimicrobial effect against the target pathogen through the
expression of the foreign gene and indirect general health benefits
through consumption of probiotics.
Materials and Methods
Bacterial Strains, Plasmids, and Growth Conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. All Listeria species were grown in brain heart infusion
(BHI, Becton Dickinson, Sparks, MD) or Luria-Bertani broth (LB,
0.5% NaCl, 1% tryptone peptone, and 0.5% yeast extract) at 37uC
for 16 to 18 h. All lactic acid bacteria except Lactococcus lactis were
cultured in deMan Rogosa Sharpe broth (MRS, Becton
Dickinson) at 37uC for 18–20 h. Lc. lactis strains were grown in
M17 broth (Becton Dickinson). Lb. rhamnosus, Lb. paracasei, and Lb.
Table 4. Cytotoxicity of Listeria monocytogenes on Caco-2 cells pretreated with Lactobacillus paracasei.
Treatment
% Cytotoxicity induced by L. monocytogenes to Caco-2 cells pretreated with Lb. paracasei for variable time
periods (Mean [SE])
a
1h 4h 1 5h 2 4h
Lb. paracasei WT (Lbp
WT)5 6 . 9 60.14 59.060.7 61.660.8 65.360.9
Lb. paracasei LAP (Lbp
LAP) 0.0960.02 7.461.5 12.760.3 13.760.6
% Protection 99.8 88.8 80 79
aLb. paracasei cultures were added to Caco-2 cells at a multiplicity of exposure (MOE) of 10:1 for 1, 4, 15, and 24 h before infection with L. monocytogenes (MOI of 10:1)
for 1 h. Cytotoxicity value for L. monocytogenes alone was 66.2163.1. Values are averages of three experiments analyzed in triplicate and are significantly different
between Lbp
WT and Lbp
LAP at all time points (P,0.05).
doi:10.1371/journal.pone.0029277.t004
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deficient mutant L. monocytogenes strain KB208 was grown in BHI
or LB with erythromycin (5 mg/mL) at 42uC. pLP401T [50] was
used for LAP expression in Lb. paracasei and was grown in
appropriate media with ampicillin (50 mg/mL) for E. coli, and
erythromycin (2 mg/mL) for Lb. paracasei. To induce expression of
LAP in recombinant Lb. paracasei, the bacterium was grown in
modified MRS (1% w/v proteose peptone, 0.5% w/v yeast
extract, 0.2% w/v meat extract, 0.1% v/v Tween 80, 37 mM
C2H3NaO2, 0.8 mM MgSO4, 0.24 mM MnSO4, 8.8 mM
C6H14N2O7 in 0.1 M potassium phosphate buffer, pH 7.0)
supplemented with mannitol (1% w/v).
Construction of Lbp
LAP
Genomic DNA from L. monocytogenes F4244 was purified and the
lap gene was amplified from genomic DNA with polymerase chain
reaction using primers LAPLmN-F 59-GACCATGGATGG-
CAATTAAAGAAAATG-39 and LAPLmX-R59-GACTCGAGT-
CAAACACCTTTGTAAG-39 (Integrated DNA Technologies,
Coralville, IA). The amplified DNA was cloned into pGEM-T
Easy Vector (Promega, Madison, WI) and designated pGEM-
LAPLm. Lactobacilli expression vector, pLP401-T was used to
express LAP in Lb. paracasei (48; Fig. 2a). This vector has been
shown to be efficient for heterologous protein delivery by
lactobacilli, owing to the presence of a secretion signal and the
leader sequence of cell wall proteinase (prtP) from Lb. casei [66].
This gene sequence codes for the secretion and surface association
of heterologous proteins to the peptidoglycan [49]. The plasmid
was digested with NcoI and XhoI, inserted into expression vector
pLP401T, and designated pLP401T-LAP. To remove the
terminator, which stabilizes the plasmid in E. coli [50],
pLP401T-LAP was digested with NotI and pLP401T-LAP was
obtained via self-ligation. Self-ligated pLP401T-LAP was trans-
formed into Lb. paracasei by electroporation. Competent Lb.
paracasei cells were prepared with incubation of 2% culture in
fresh MRS broth containing 0.5% sucrose and 0.5% glycine at
37uC until OD600 reached to 0.5 , 0.8. The cells were harvested
(3,9006g for 5 min at 4uC), washed twice with washing buffer
(0.5 M sucrose, 10% glycerol) and collected. Then the cells were
resuspended in the same washing buffer and stored at – 80uC. For
electroporation, 50 ml of competent cells mixed with 0.5 mgo f
purified plasmid DNA in an ice cold cuvette with a 2-mm
electrode gap. The electric pulse was delivered by the Gene Pulser
XcellTM electroporation system (Bio-Rad, Richmond, CA) using
the following parameter settings: 1.5 kV, 200V and 25 mF. After
electroporation, competent cells were recovered in 1 ml of MRS
containing 0.5 M sucrose, 20 mM MgCl2, 2 mM CaCl2 at 37uC
for 2 h in water bath. Transformants were selected using MRS
agar containing 2 mg/mL of erythromycin [52]. Similarly, another
recombinant strain was generated carrying the pLP401-T plasmid
with no LAP insert to be used as a vector control (Lbp
LAP-).
Identity of recombinant and WT Lb. paracasei strains were
confirmed by ribotyping using an automated RiboPrinterH
(DuPont Qualicon, Wilmington, DE). Protein expression in
recombinant strains was confirmed with Western blot analysis.
Analysis of LAP Expression by Lb. paracasei
LAP expression in SN, CW, and intracellular fractions was
analyzed. SN was collected from centrifuged culture (7,0006g for
10 min at 4uC) and the pellet was retained for preparation of CW
and intracellular proteins. The SN was filtered (0.22-mm filter),
precipitated with 10% trichloroacetic acid for 40 min on ice, and
centrifuged (14,0006ga t4 uC for 10 min). The pellet was
resuspended in ice-cold acetone and centrifuged. The remaining
acetone was evaporated, and the pellet was resuspended in alkaline
rehydration buffer (100 mM Tris-base, 3% SDS, 3 mM dithio-
threitol, pH 11), boiled for 5 min, and stored at 220uC.
For the CW protein fraction, the pellet was resuspended in 5 M
LiCl with 5 mM EDTA and incubated for 30 min in a water bath
at 37uC. The suspension was centrifuged (13,0006ga t4 uC for
5 min) and the SN was filtered (0.45-mm filter). The sample was
dialyzed using ultrapure water supplemented with 5 mM EDTA
and stored at 220uC.
Figure 7. Microscopic analysis of protection of Caco-2 cells
from Listeria monocytogenes (Lm)-mediated damage by recom-
binant Lb. paracasei (Lbp
LAP). Caco-2 cells pre-exposed to wild type
Lb. paracasei (Lbp
WT) or Lbp
LAP for 15 h before infection with Lm for 1 h
were stained with a mixture of acridine orange (green) for live cells and
propidium iodide (red) for dead cells. Orange-red cells in the merged
picture indicate dead or dying cells. Bar, 10 mm.
doi:10.1371/journal.pone.0029277.g007
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intracellular protein isolation. It was resuspended in the sample
solvent (5% SDS, 0.5% b-mercaptoethanol, 1.5% Tris, pH 7.0)
and sonicated on ice for 5–7 cycles of 15 sec each using a Sonifier
150D (Branson, Niantic, CT). The sample was centrifuged and the
SN was collected and stored at 220uC. SN and CW protein
preparations were also tested with a PepC assay [75] to rule out
contamination with intracellular or membrane proteins.
Proteins were quantified using the bicinchoninic acid method
(Pierce, Rockford, IL) and equivalent amounts of protein (40 mgo f
each fraction) were separated using SDS polyacrylamide gel
electrophoresis (7.5% acrylamide) gel. The proteins were trans-
ferred to an Immobilon-P membrane (Millipore, Billerica, MA)
and immunoprobed with anti-LAP antibody MAb-H7 (1.0 mg/
mL) and horseradish peroxidase-coupled anti-mouse antibody
(0.2 mg/mL; Jackson Immuno Research, West Grove, PA). The
membranes were developed with an enhanced chemiluminescence
kit (Pierce).
LAP expression in recombinant probiotics was also determined
by reacting 18-h grown bacterial cells first with MAb-H7 for 1 h
followed by FITC-labeled anti-mouse monovalent secondary Fab
fragment (diluted 1:250 in phosphate-buffered saline [PBS];
Jackson Immuno Research) for 1 h and counterstained with
Hoechst dye (0.5 mg/mL in PBS; Invitrogen) for nucleus staining.
Cells were washed between antibody treatments with PBS
containing 1% bovine serum albumen and examined under a
fluorescence microscope (Leica, model DMLB, Wetzlar, Ger-
many) equipped with SPOT software (version 4.6.4.2, Diagnostic
Instruments, Sterling Heights, MI, USA).
Analysis of Recombinant Probiotic Interaction with
Hsp60-Coated Paramagnetic Beads
A magnetic bead capture method was used to analyze the
interactions of surface-associated LAP on the recombinant
probiotic with human Hsp60. Paramagnetic beads (MyOne
TM
Streptavidin C1 beads; average diameter, 1.0 mm; Invitrogen,
Carlsbad, CA) were coated with biotinylated Hsp60 as described
elsewhere [51]. Briefly, PBS-washed, overnight-grown bacterial
cells (250 mL) were mixed gently with Hsp60-coated beads (20 mL)
and incubated at 25uC for 1 h on a vortex mixer. The beads were
removed using a magnetic particle concentrator (MPC-S; Invitro-
gen) and washed three times with PBS (20 mM, pH 7.0) and once
with PBS containing 0.5% Tween 20. Captured bacteria were
mechanically separated from the beads by vigorous vortexing;
lactobacilli were quantified by plating on MRS agar (Becton
Dickinson) and Listeria on modified oxford (MOX) agar (Becton
Dickinson) plates after incubation at 37uC for 24–48 h.
Caco-2 Cell Culture
Human colon carcinoma cell line Caco-2 (HTB37; American
Type Culture Collection) was cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum
(D10F; Atlanta Biologicals, Norcross, GA). Passages of 20–35 were
used for the experiments, and the cells were grown in 12- and 24-
well plates at 37uC in the presence of 7% CO2 in a cell culture
incubator for 10–12 days or until monolayers formed with no
further visible differentiation.
Adhesion Assays
The adhesion profiles of bacteria (10
6 cfu/well) to Caco-2 cells
(10
5 cells/well) with multiplicity of exposure (MOE) of 10:1 were
analyzed using adhesion assays [13]. Adhered LAB was enumer-
ated on MRS and Listeria on MOX agar plates. Additionally,
bacterial adhesion to cell monolayers grown on glass coverslips
was done by Giemsa staining followed by microscopic examina-
tion [76] to visualize bacterial attachment qualitatively.
To verify LAP-mediated binding, bacterial cells were also
pretreated with anti-LAP antibody before use in the adhesion
experiment [16]. As an immunoglobulin G isotype control, MAb
EM-7G1 that reacts with a 66-kDa protein in L. monocytogenes was
used.
Invasion Assay
Invasion of bacteria was analyzed as previously described
[76,77]. Bacteria were added to Caco-2 cells at an MOE of 10:1
and incubated for 1 h. The monolayers were washed with D10F,
and an additional 1 h of incubation in D10F containing 50 mg/
mL gentamicin followed. The cells were lysed with 0.1% Triton
X-100 and plated for enumeration of internalized bacteria.
Transepithelial Translocation Assay
Transepithelial bacterial translocation assay was performed as
previously described [21,78]. Briefly, Caco-2 cells were grown on
transwell filter inserts (4-mm pore filter; Corning, Lowell, MA) for
10–12 days to reach confluence. Bacteria were added to the apical
well of the insert and incubated for 2 h. Liquid from the basal well
was removed, serially diluted if needed, and distributed onto plates
for enumeration. TEER of Caco-2 cells before and after treatment
was measured using a Millicell ERS system (Millipore, Billerica,
MA).
Competitive Exclusion of L. monocytogenes by LAB
Strains
Competitive exclusion was determined using competitive
adhesion, inhibition of adhesion, and displacement experiments
[ 1 0 ] .Ar a t i oo f1 0 : 1o fL. monocytogenes or LAB strains to Caco-2
cells was used. (i) Competitive adhesion: L. monocytogenes and LAB
strains were added simultaneously to Caco-2 cells and incubated
for 1 h. To remove unbound bacteria, we washed the cells four
times with Cell-PBS (137 mM NaCl, 5.4 mM KCl, 3.5 mM
Na2HPO4,4 . 4 m MN a H 2PO4,1 1 m Mg l u c o s e ,p H 7 . 2 ) .
Adherent bacteria were released by treatment with 0.1%
Triton-X 100 in Cell-PBS and plated onto MOX for L.
monocytogenes and MRS agar for LAB strains. (ii) Inhibition of
adhesion: LAB strains were added to wells containing Caco-2
cells and incubated for 1 h. Unbound bacteria were removed by
w a s h i n gw i t hD 1 0 Fa sa b o v e ,a n dL. monocytogenes was then added
and incubated for 1 h. The cells were then washed. Bound
bacteria were released and plated as above. (iii) Displacement: L.
monocytogenes were added to Caco-2 cells and incubated for 1 h.
After washing with D10F, each LAB strain was added and
incubated for 1 h. The cells were then washed. Bound bacteria
were released and plated as above.
Inhibition of L. monocytogenes Adhesion, Invasion, and
Translocation by Lbp
LAP
The ability of Lbp
LAP to inhibit L. monocytogenes adhesion,
invasion, and translocation to Caco-2 cells was investigated as
described elsewhere [79]. Lbp
LAP and Lbp
WT were added to each
well and incubated for 1, 4, 15, or 24 h. Unbound bacteria were
removed by washing with D10F, and L. monocytogenes was added
(MOI; 10:1) and incubated for 1 h for inhibition of adhesion and
invasion experiments and 2 h for inhibition of translocation
experiments. The cells were then washed. Bound bacteria were
released by Triton-X treatment and plated as above. As a vector
control, the recombinant Lbp
LAP- strain was used to rule out the
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L. monocytogenes infection.
Epithelial Tight Junction Integrity Analysis
Tight junction permeability of Caco-2 monolayers in transwell
filter inserts (4-mm pore size; Corning) pre-exposed to probiotics
for 1, 4, 15 and 24 h and infected with L. monocytogenes for 2 h was
assessed by monitoring Dextran
FITC (Mr 3–5 kDa; Sigma)
permeability as described elsewhere [80]. MOE for all bacterial
strains was 10:1. Dextran
FITC (1 mg/ml) was added to the
transwell and incubated at 37uC for 1 h. Samples from the apical
and basolateral chambers were collected and read in a
SpectraMax Gemini EM fluorescent plate reader (Molecular
Devices; Sunnyvale, CA). The data are expressed as percentages of
the apical dextran recovered in the basal chamber.
Cytotoxicity Assay and Fluorescence Microscopy
Caco-2 cell cytotoxicity was assessed using a lactate dehydro-
genase cytotoxicity assay kit (Roche). Caco-2 cell viability was also
assessed with live and dead staining of Caco-2 monolayers using a
propidium iodide (PI; red, dead cell indicator) and acridine orange
(AO, green, live cell indicator) mixture (PI; 100 mg/mL and AO;
20 mg/mL; Sigma) as described previously [81]. Stained cells were
washed in Cell-PBS, fixed in methanol, and examined under a
fluorescence microscope (Leica) equipped with SPOT software
(Diagnostic Instruments) using green (for AO) and red (for PI)
filters.
Statistical Analysis
All experiments were repeated at least three times indepen-
dently, and each set of experiments was performed in duplicate or
triplicate. Statistical comparisons were carried out using analysis of
variance (SAS 9.2, Cary, NC) and Tukey’s multiple comparisons
of means at P,0.05 to determine significant differences.
Supporting Information
Figure S1 Competitive exclusion analysis of Listeria
monocytogenes by different Lactobacillus species to
Caco-2 cells. Three adhesion methods were used; (a) competitive
adhesion, (b) inhibition of adhesion, and (c) displacement. First bar
shows adhesion of L. monocytogenes to Caco-2 cells without
pretreatment of LAB and presented as 100%. Tables (a1, b1, c1)
under bar graph show percent adhesion values of L. monocytogenes
with and without Lb. rhamnosus, Lb. acidophilus and Lb. paracasei. Also
adhesion of each Lactobacillus species in the presence (w) and
absence (w/o) of L. monocytogenes was shown. The data are average
6 SD of three independent experiments analyzed in duplicate.
(TIF)
Figure S2 Displacement of Listeria monocytogenes
adhesion following pretreatment of Caco-2 cells with
different (a) lactic acid bacterial (LAB) strains and (b)
different ratios of Lactobacillus rhamnosus or Lb.
acidophilus to L. monocytogenes. First bar shows adhesion
of L. monocytogenes to Caco-2 cells without pretreatment of LAB and
presented as 100%. Other bars indicate relative adhesion rate of L.
monocytogenes after addition of each LAB. The data are average 6
SD of two independent experiments performed in triplicate.
(TIF)
Figure S3 Binding (capture) analysis of different lacto-
bacilli to Hsp60 coated paramagnetic beads. First bar
shows capture rate of L. monocytogenes to Hsp60-coated beads and
presented as 100%. Other bars indicate relative capture rate for
other bacteria. The data are average 6 SD of two independent
experiments performed in duplicate.
(TIF)
Figure S4 Adhesion characteristics of bacteria to Caco-
2 cells pretreated with anti-Hsp60 antibody. (a) Adhesion
of L. monocytogenes to Caco-2 cell monolayers that were pre-treated
with anti-Hsp60 monoclonal antibody (1 mg/well for 1 h) or an
isotype IgG control antibody (purified MAb C11E9 specific for L.
monocytogenes) followed by exposure to Lbp
WT, recombinant
Lbp
LAP, and a vector control, i,e., Lb. paracasei containing empty
vector, pLP401-T without any LAP insert (Lbp
LAP-) for 1 h.
Adherent bacterial counts were determined by plating following
lysis of cells using Triton-X 100. (b) Adhesion characteristics of
Lbp
WT and Lbp
LAP to Caco-2 cells pretreated with anti-Hsp60
MAb or an isotype antibody MAb C11E9.
(TIF)
Table S1 Sequence similarity between LAP, an alcohol
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